Global Cancer Biomarkers Market Report 2017

Press Release   •   Aug 17, 2017 01:30 EDT

“Global Cancer Biomarkers Market 2017- Research Report”

In this report, the cancer biomarkers market is segmented on the basis of type, cancer type, profiling technology, application, and geography.Based on type, the cancer biomarkers market is broadly split into three segments, namely, protein biomarkers, genetic biomarkers, and other biomarkers (includes viral, cell, and carbohydrate biomarkers).

Download sample pages of this report:

In 2017, the protein biomarkers segment accounted for the largest share of the global cancer biomarkers market. The large share of this segment is mainly attributed to the tremendous potential of protein biomarkers in cancer detection, diagnostics, prognostics, and clinical & therapeutic applications; and low cost of the protein biomarker tests as compared to genetic biomarker tests. The increasing focus of pharmaceutical companies towards the discovery of protein biomarkers is further expected to fuel the growth of this market in the coming years. However, the genetic biomarkers segment is expected to grow at the highest CAGR during the forecast period. The high growth rate of this segment can be attributed to the increasing advancements in genomics technologies and rising adoption of high-throughput sequencing technologies in biomarker discovery and development.

This report studies Cancer Biomarkers in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering

Abbott Laboratories (U.S.)

Affymetrix Inc. (U.S.)

Roche Diagnostics Ltd. (Switzerland)

Illumina, Inc. (U.S.)

Qiagen NV (Netherlands)

Agilent Technologies (U.S.)

Thermo Fisher Scientific Inc. (U.S.)

Merck & Co. Inc. (U.S.)

Becton Dickinson and Company (U.S.)

Hologic Inc. (U.S.)

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Cancer Biomarkers in these regions, from 2011 to 2021 (forecast), like

North America




Southeast Asia


Split by product type, with production, revenue, price, and market share and growth rate of each type, can be divided into

Protein Biomarkers

Genetic Biomarkers


Split by application, this report focuses on consumption, market share and growth rate of Cancer Biomarkers in each application, can be divided into


Drug Discovery and Development


Risk Assessment


Download sample pages of this report:

About Us:

Key Market Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns.


+1 (888) 278-7681